Benzodiazepine receptors: localization in rat amygdala

Area of Science:

• Neuroscience
• Pharmacology
• Neuroanatomy

Background:

• Behavioral and electrophysiological studies suggest the amygdala, especially the basolateral division, is key for benzodiazepine (BZ) therapeutic effects.
• Understanding BZ receptor distribution in the amygdala can identify specific nuclei and pathways sensitive to these drugs.

Purpose of the Study:

• To map the localization of type 1 and type 2 BZ receptors within the rat amygdaloid nuclear complex.
• To correlate BZ receptor distribution with known amygdala functions in drug action.

Main Methods:

• Quantitative light microscopic autoradiography using [3H]flunitrazepam to label BZ receptors.
• Selective displacement of type 1 BZ receptors using CL218,872 in rat brain sections.
• Analysis of ten amygdaloid nuclei across nine rostrocaudal levels.

Main Results:

• Highest total BZ receptor density was observed in the basolateral nuclear complex, predominantly of type 2.
• Type 1 BZ receptors were concentrated in anterior amygdala regions, notably the anterior cortical nucleus.
• Specific BZ receptor subtypes show distinct regional distributions within the amygdala.

Conclusions:

• The basolateral amygdala plays a significant role in anxiogenesis and seizure induction, consistent with its high BZ receptor density.
• A broader neural circuit involving the amygdala, hypothalamus, thalamus, and frontal cortex may mediate the anxiolytic effects of benzodiazepines.